Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Cell Death Dis ; 13(2): 144, 2022 02 10.
Article in English | MEDLINE | ID: mdl-35145061

ABSTRACT

Malaria is an enormous burden on global health that caused 409,000 deaths in 2019. Severe malaria can manifest in the lungs, an illness known as acute respiratory distress syndrome (ARDS). Not much is known about the development of malaria-associated ARDS (MA-ARDS), especially regarding cell death in the lungs. We had previously established a murine model that mimics various human ARDS aspects, such as pulmonary edema, hemorrhages, pleural effusion, and hypoxemia, using DBA/2 mice infected with Plasmodium berghei ANKA. Here, we explored the mechanisms and the involvement of apoptosis in this syndrome. We found that apoptosis contributes to the pathogenesis of MA-ARDS, primarily as facilitators of the alveolar-capillary barrier breakdown. The protection of pulmonary endothelium by inhibiting caspase activation could be a promising therapeutic strategy to prevent the pathogenicity of MA-ARDS. Therefore, intervention in the programmed death cell mechanism could help patients not to develop severe malaria.


Subject(s)
Malaria , Respiratory Distress Syndrome , Animals , Caspases/metabolism , Disease Models, Animal , Humans , Lung/metabolism , Malaria/complications , Malaria/metabolism , Mice , Mice, Inbred DBA
2.
Biomed Res Int ; 2017: 7651815, 2017.
Article in English | MEDLINE | ID: mdl-28503574

ABSTRACT

Background/Aims. The effects of cholecalciferol supplementation on the course of diabetes in humans and animals need to be better understood. Therefore, this study investigated the effect of short-term cholecalciferol supplementation on biochemical and hematological parameters in mice. Methods. Male diabetic (alloxan, 60 mg/kg i.v., 10 days) and nondiabetic mice were supplemented with cholecalciferol for seven days. The following parameters were determined: serum levels of 25-hydroxyvitamin D, phosphorus, calcium, urea, creatinine, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, red blood cell count, white blood cell count (WBC), hematocrit, hemoglobin, differential cell counts of peritoneal lavage (PeL), and bronchoalveolar lavage (BAL) fluids and morphological analysis of lung, kidney, and liver tissues. Results. Relative to controls, cholecalciferol supplementation increased serum levels of 25-hydroxyvitamin D, calcium, hemoglobin, hematocrit, and red blood cell counts and decreased leukocyte cell counts of PeL and BAL fluids in diabetic mice. Diabetic mice that were not treated with cholecalciferol had lower serum calcium and albumin levels and hemoglobin, WBC, and mononuclear blood cell counts and higher serum creatinine and urea levels than controls. Conclusion. Our results suggest that cholecalciferol supplementation improves the hematological parameters and reduces leukocyte migration into the PeL and BAL lavage of diabetic mice.


Subject(s)
Cholecalciferol/administration & dosage , Diabetes Mellitus, Experimental/diet therapy , Dietary Supplements , Vitamin D/metabolism , Alkaline Phosphatase/blood , Animals , Aspartate Aminotransferases/blood , Cell Movement/drug effects , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/pathology , Erythrocyte Count , Humans , Leukocyte Count , Liver/drug effects , Liver/metabolism , Lung/drug effects , Lung/metabolism , Mice , Mice, Inbred NOD/metabolism , Peritoneal Cavity/pathology , Vitamin D/analogs & derivatives , Vitamin D/blood
SELECTION OF CITATIONS
SEARCH DETAIL